Gene doping is the hypothetical non-therapeutic use of gene therapy by athletes in order to improve their performance in those sporting events which prohibit. Check out my latest presentation built on , where anyone can create & share professional presentations, websites and photo albums in minutes. Crecimiento y. Dopaje Genético. Jordi Segura. Laboratorio Acreditado AMA, IMIM-Hospital del Mar,. Parque de Investigación Biomédica PRBB, Barcelona;.

Author: Dirisar Dubar
Country: Albania
Language: English (Spanish)
Genre: Art
Published (Last): 10 December 2009
Pages: 333
PDF File Size: 10.13 Mb
ePub File Size: 11.53 Mb
ISBN: 270-2-94732-969-2
Downloads: 29865
Price: Free* [*Free Regsitration Required]
Uploader: Vojind

February 18, News Release: In some cases, however, irreversible side effects, such as unexpected endogenous virus recombination, may occur. Viral expression of insulin—like growth factor—I enhances muscle hypertrophy in resistance—trained rats. Gene expression profiling assesses the expression profile of endogenous genes that may be modified following the genetixo of the introduced gene [ 52767 ].

In vitro studies improve the production of human recombinant proteins, such as insulin INSgrowth hormone GHinsulin-like growth factor-1 IGF-1 and erythropoietin EPOwhich could have therapeutic application.

This type of problem includes a plurality of protein isoforms encoded by a single gene and the similarity of genetically modified proteins to their endogenous counterparts. Epoetin alpha, epoetin beta and darbepoetin alfa: Systematic and periodic testing of athletes — in order to detect the antibodies against viral vectors — would be required to monitor the level of anti-viral antibodies, which could potentially be used as a method for the detection of gene doping.

Gene doping

The drug is administered intramuscularly, and consists of a viral vector transferring the modified human EPO gene under the control of ropaje encoding proteins of oxygen homeostasis e. Jager L, Ehrhardt A. It seems that the evaluation of the host immune response to the viral vector is also an effective approach, but it requires refinement.

Gene doping is the hypothetical non-therapeutic use of gene therapy by athletes in order to improve their performance in those sporting events which prohibit such applications of genetic modification technology, [1] [2] and for reasons other than the treatment of disease. Applied genetics Doping in sport. In addition to educational programmes for athletes, and development of tests for gene doping detection, an individual method of gene doping control should be introduced, in which each athlete would be the self-reference baseline.



However, IGF1 delivery may lead to profound hypoglycaemia, similar to the administration of insulin. However, there is anecdotal evidence that recombinant GH rGH is commonly abused by athletes. Structure and generico of the growth—hormone— releasing hormone receptor.

GH also affects carbohydrate metabolism stimulation of glycogenolysis and increased glucose release from the liverfat metabolism increased lipolysis and decreased lipogenesis and protein metabolism increased protein synthesis [ 38 ].

Furthermore, gene expression can be modulated as desired using the appropriate pharmacotherapy. Archived from the original on 13 November This technique is based on the detection of minor structural differences between the recombinant proteins — which result from the expression of transgenes — and their endogenous counterparts. It is a key enzyme regulating gluconeogenesis.

Based on this method, there is a possibility to develop microarray chips for expression analysis of the panel of genes that can be used in gene doping.

Detenido en Colombia Alberto Beltrán, pionero del dopaje genético en España

Transfer of the phosphoenolpyruvate carboxykinase Pck1 gene resulted in increased activity of the transgenic mice, increased strength and speed during a race, and additionally, the mice were characterized by lower mass and fat content as compared to control mice [ 25 ].

Inthe field of gene therapy was set back when Jesse Gelsinger died in a gene therapy clinical trial, suffering a massive dipaje reaction to the drug. Detection of genetick carrier used in gene doping, usually a vector used to transduce the geneis possible in the site of intramuscular injection or tissues within weeks, and often months, after the application of doping. Scientists supported by the WADA are looking for effective methods and tests fenetico the detection of gene doping used currently in sport.

HIF-1 regulates oxygen homeostasis, thus facilitating the cell’s adaptation to low oxygen conditions. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. New aspects of erythropoietin treatment. Mini Rev Med Chem. J Am Coll Cardiol. Please review our privacy policy. Physical methods of gene delivery allow DNA transfer into the cell cytoplasm or nucleus, through local and reversible damage of the cell membrane.


Glybera approved by European Commission. Directly detecting the use of gene therapy usually requires the discovery of recombinant proteins or gene insertion vectorswhile most indirect methods involve examining the athlete in an attempt to detect bodily changes or structural differences between endogenous and recombinant proteins.

Aug 18, Andy Miah. New hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. If your email exists in our system, we’ll send you an email with a link to reset your password. Additionally, viral vectors can be recognized by the host immune system, resulting in an increased immune response.


Novel nonviral vectors target cellular signaling pathways: Social Studies of Science. A common haplotype and the ProSer polymorphism of the hypoxia—inducible factor—1alpha HIF1A gene in elite endurance athletes. Registration is free and requires only your email address. In gene therapy and, similarly, in gene doping the genetic material is delivered into cells and tissues using various carriers that can be viral or non-viral [ 10 ].

Erythropoietin EPO The EPO gene encodes a glycoprotein hormone that increases the number of red blood cells and the amount of oxygen in the blood, thereby increasing the oxygen supply to the muscles [ 2943 ].

Biochemical methods involve the use of chemical vopaje, which form fenetico with nucleic acids to neutralize their negative charge.

For this reason, intensive investigations on the potential use of gene doping in many sports are nowadays increasing in number.